Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GWH
3426
DELISTED
ESS Tech
GWH
| $36.7K | ﹤0.01% |
27,560
+11,700
| +74% | +$21.9K |
2023 Q4
6 quarters
|
|
3427
ALX Oncology
ALXO
$163M
| $35.4K | ﹤0.01% |
85,399
+71,100
| +497% | +$35.9K |
2025 Q1
1 quarter
|
|
|
XTKG
3428
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
| $34.9K | ﹤0.01% |
120
+6
| +5% | +$1.42K |
2024 Q4
2 quarters
|
|
|
BRNS
3429
DELISTED
Barinthus Biotherapeutics
BRNS
| $33.8K | ﹤0.01% |
36,300
+600
| +2% | +$524 |
2023 Q1
9 quarters
|
|
3430
Hyperfine
HYPR
$99.7M
| $33.7K | ﹤0.01% |
46,900
+28,600
| +156% | +$20K |
2023 Q4
6 quarters
|
|
|
HKD
3431
AMTD Digital
HKD
$534M
| $33.6K | ﹤0.01% |
+19,200
| New | +$38.3K |
2025 Q2
0 quarters
|
|
3432
Boxlight
BOXL
$2.79M
| $33.4K | ﹤0.01% |
527
-53
| -9% | -$3.1K |
2021 Q1
17 quarters
|
|
3433
X4 Pharmaceuticals
XFOR
$277M
| $33K | ﹤0.01% |
17,366
+16,696
| +2,492% | +$68.3K |
2025 Q1
1 quarter
|
|
3434
Cenntro
CENN
$9.58M
| $32.5K | ﹤0.01% |
699
+177
| +34% | +$9.15K |
2024 Q4
2 quarters
|
|
3435
ClearSign Technologies
CLIR
$21.2M
| $32.5K | ﹤0.01% |
5,800
-1,702
| -23% | -$10.3K |
2024 Q4
2 quarters
|
|
|
MOGU
3436
MOGU Inc
MOGU
$15.3M
| $32K | ﹤0.01% |
15,057
-100
| -0.7% | -$215 |
2019 Q2
24 quarters
|
|
3437
Socket Mobile
SCKT
$5.16M
| $31.4K | ﹤0.01% |
27,344
-20,756
| -43% | -$23.8K |
2016 Q4
34 quarters
|
|
|
ZKH
3438
ZKH Group
ZKH
$325M
| $31K | ﹤0.01% |
10,100
-29,867
| -75% | -$89.7K |
2025 Q1
1 quarter
|
|
3439
Royalty Management
RMCO
$37.9M
| $30.8K | ﹤0.01% |
+23,700
| New | +$26.8K |
2025 Q2
0 quarters
|
|
3440
Wah Fu Education Group
WAFU
$6.4M
| $30.7K | ﹤0.01% |
21,900
-18,700
| -46% | -$27K |
2025 Q1
1 quarter
|
|
3441
Versus Systems
VS
$6.65M
| $30.5K | ﹤0.01% |
+13,100
| New | +$27.3K |
2025 Q2
0 quarters
|
|
|
SYBX
3442
DELISTED
Synlogic
SYBX
| $30.2K | ﹤0.01% |
23,810
+300
| +1% | +$346 |
2023 Q4
6 quarters
|
|
3443
Shattuck Labs
STTK
$568M
| $30.2K | ﹤0.01% |
38,100
+10,100
| +36% | +$9.79K |
2021 Q4
14 quarters
|
|
3444
Cognition Therapeutics
CGTX
$85.1M
| $29.9K | ﹤0.01% |
96,400
+40,700
| +73% | +$13.7K |
2023 Q4
6 quarters
|
|
|
QH
3445
Quhuo Ltd
QH
$10.1M
| $29.6K | ﹤0.01% |
274
+1
| +0.4% | +$112 |
2024 Q4
2 quarters
|
|
3446
Lightwave Logic
LWLG
$788M
| $29.3K | ﹤0.01% |
+23,600
| New | +$24.8K |
2025 Q2
0 quarters
|
|
|
MURA
3447
DELISTED
Mural Oncology
MURA
| $29.1K | ﹤0.01% |
+11,800
| New | +$27.8K |
2025 Q2
0 quarters
|
|
3448
Aterian
ATER
$10.9M
| $28.8K | ﹤0.01% |
+17,347
| New | +$29.5K |
2025 Q2
0 quarters
|
|
3449
Drilling Tools International
DTI
$70.9M
| $28.6K | ﹤0.01% |
10,040
-27,200
| -73% | -$67.7K |
2024 Q3
3 quarters
|
|
|
PW
3450
Power REIT
PW
$2.56M
| $27.9K | ﹤0.01% |
2,582
-58
| -2% | -$653 |
2013 Q2
48 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.